메뉴 건너뛰기




Volumn 95, Issue 1, 2011, Pages 56-68

Efficacy and safety of anti-vascular endothelial growth factor (VEGF) therapy with intravitreal ranibizumab (Lucentis) for naive retinal vein occlusion: 1-Year follow-up

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN A;

EID: 78650824570     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.174060     Document Type: Article
Times cited : (40)

References (46)
  • 1
    • 0020559889 scopus 로고
    • Classification of central retinal vein occlusion
    • Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458-74.
    • (1983) Ophthalmology , vol.90 , pp. 458-474
    • Hayreh, S.S.1
  • 2
    • 0034527456 scopus 로고    scopus 로고
    • The epidemiology of retinal vein occlusion: The Beaver Dam Eye Study
    • Klein R, Klein B, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2001;98:133-41.
    • (2001) Trans Am Ophthalmol Soc , vol.98 , pp. 133-141
    • Klein, R.1    Klein, B.2    Moss, S.E.3
  • 3
    • 42249083700 scopus 로고    scopus 로고
    • The 15-year cumulative incidence of retinal vein occlusion. The Beaver Dam Eye Study
    • Klein R, Moss SE, Meuer SM, et al. The 15-year cumulative incidence of retinal vein occlusion. The Beaver Dam Eye Study. Arch Ophthalmol 2008;126:513-18.
    • (2008) Arch Ophthalmol , vol.126 , pp. 513-518
    • Klein, R.1    Moss, S.E.2    Meuer, S.M.3
  • 4
    • 33747191766 scopus 로고    scopus 로고
    • Venous occlusive disease: Management 25 years ago
    • Hayreh SS. Venous occlusive disease: management 25 years ago. Retina 2006;26(6 Suppl):51-62.
    • (2006) Retina , vol.26 , Issue.6 SUPPL. , pp. 51-62
    • Hayreh, S.S.1
  • 5
    • 0027409968 scopus 로고
    • Arteriovenous crossing patterns in branch retinal vein occlusion
    • Zhao J, Sastry SM, Sperduto RD, et al. Arteriovenous crossing patterns in branch retinal vein occlusion. Ophthalmology 1993;100:423-8.
    • (1993) Ophthalmology , vol.100 , pp. 423-428
    • Zhao, J.1    Sastry, S.M.2    Sperduto, R.D.3
  • 6
    • 0024357181 scopus 로고
    • Anterior location of the crossing artery in branch retinal vein obstruction
    • Duker JS, Brown GC. Anterior location of the crossing artery in branch retinal vein obstruction. Arch Ophthalmol 1989;107:998-1000. (Pubitemid 19183656)
    • (1989) Archives of Ophthalmology , vol.107 , Issue.7 , pp. 998-1000
    • Duker, J.S.1    Brown, G.C.2
  • 7
    • 0033505069 scopus 로고    scopus 로고
    • Pathophysiology and hemodynamics of branch retinal vein occlusion
    • Christoffersen NL, Larsen M. Pathophysiology and hemodynamics of branch retinal vein occlusion. Ophthalmology 1999;106:2054-62.
    • (1999) Ophthalmology , vol.106 , pp. 2054-2062
    • Christoffersen, N.L.1    Larsen, M.2
  • 8
    • 0018166604 scopus 로고
    • Systemic factors contributory to retinal vein occlusion
    • McGrath MA, Wechsler F, Hunyor AB, et al. Systemic factors contributory to retinal vein occlusion. Arch Intern Med 1978;138:216-20.
    • (1978) Arch Intern Med , vol.138 , pp. 216-220
    • McGrath, M.A.1    Wechsler, F.2    Hunyor, A.B.3
  • 9
    • 53449090577 scopus 로고    scopus 로고
    • Traditional and novel cardiovascular risk factors for retinal vein occlusion: The Multiethnic Study of Atherosclerosis
    • Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the Multiethnic Study of Atherosclerosis. Inv Ophthalmol Vis Sci 2008;49:4297-302.
    • (2008) Inv Ophthalmol Vis Sci , vol.49 , pp. 4297-4302
    • Cheung, N.1    Klein, R.2    Wang, J.J.3
  • 10
    • 3142624510 scopus 로고    scopus 로고
    • Risk factors for central retinal vein occlusion
    • The Eye Disease Case-Control Study Group
    • The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114:545-54.
    • (1996) Arch Ophthalmol , vol.114 , pp. 545-554
  • 11
    • 0027319901 scopus 로고
    • Risk factors for branch retinal vein occlusion
    • Eye Disease Case-Control Study Group
    • Eye Disease Case-Control Study Group. Risk factors for branch retinal vein occlusion. Am J Ophthalmol 1993;116:286-96.
    • (1993) Am J Ophthalmol , vol.116 , pp. 286-296
  • 12
    • 0348048862 scopus 로고    scopus 로고
    • Intraocular Pressure Abnormalities Associated with Central and Hemicentral Retinal Vein Occlusion
    • DOI 10.1016/j.ophtha.2003.03.002
    • Hyreh SS, Zimmermann BM, Beri M, et al. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology 2004;111:133-41. (Pubitemid 38032221)
    • (2004) Ophthalmology , vol.111 , Issue.1 , pp. 133-141
    • Hayreh, S.S.1    Zimmerman, M.B.2    Beri, M.3    Podhajsky, P.4
  • 13
    • 0034525720 scopus 로고    scopus 로고
    • Hyperhomocysteinemia: A new risk factor for central retinal vein occlusion
    • Vine AK. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 2000;98:493-503.
    • (2000) Trans Am Ophthalmol Soc , vol.98 , pp. 493-503
    • Vine, A.K.1
  • 14
    • 0031940281 scopus 로고    scopus 로고
    • Vascular endothelial growth factor upregulation in human central retinal vein occlusion
    • Pe'er J, Folberg R, Itin A, et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998;105:412-16.
    • (1998) Ophthalmology , vol.105 , pp. 412-416
    • Pe'Er, J.1    Folberg, R.2    Itin, A.3
  • 15
    • 23744502535 scopus 로고    scopus 로고
    • Pathogenesis of macular oedema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6
    • Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular oedema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005;140:256-61.
    • (2005) Am J Ophthalmol , vol.140 , pp. 256-261
    • Noma, H.1    Funatsu, H.2    Yamasaki, M.3
  • 16
    • 4143136640 scopus 로고    scopus 로고
    • Vascular endothelial growth factor: Basic science and clinical progress
    • DOI 10.1210/er.2003-0027
    • Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004;25:581-611. (Pubitemid 39099316)
    • (2004) Endocrine Reviews , vol.25 , Issue.4 , pp. 581-611
    • Ferrara, N.1
  • 17
    • 33749632278 scopus 로고    scopus 로고
    • Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular agerelated macular degeneration
    • Ferrara N, Damico L, Shams N, et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular agerelated macular degeneration. Retina 2006;26:859-70.
    • (2006) Retina , vol.26 , pp. 859-870
    • Ferrara, N.1    Damico, L.2    Shams, N.3
  • 18
    • 33646446084 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) treatment of macular oedema in central retinal vein occlusion: A short-term study
    • Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular oedema in central retinal vein occlusion: a short-term study. Retina 2006;26:279-84.
    • (2006) Retina , vol.26 , pp. 279-284
    • Iturralde, D.1    Spaide, R.F.2    Meyerle, C.B.3
  • 19
    • 33846945424 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: The IBeVO study
    • Costa RA, Jorge R, Calucci D, et al. Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: the IBeVO study. Retina 2007;27:141-9.
    • (2007) Retina , vol.27 , pp. 141-149
    • Costa, R.A.1    Jorge, R.2    Calucci, D.3
  • 20
    • 34247231034 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion
    • Rabena MD, Pieramici DJ, Castellarin AA, et al. Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion. Retina 2007;27:419-25.
    • (2007) Retina , vol.27 , pp. 419-425
    • Rabena, M.D.1    Pieramici, D.J.2    Castellarin, A.A.3
  • 21
    • 33947401512 scopus 로고    scopus 로고
    • Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion
    • Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007;143:601-6.
    • (2007) Am J Ophthalmol , vol.143 , pp. 601-606
    • Pai, S.A.1    Shetty, R.2    Vijayan, P.B.3
  • 22
    • 36248981014 scopus 로고    scopus 로고
    • Early bevacizumab treatment of central retinal vein occlusion
    • Ferrara DC, Koizumi H, Spaide RF. Early bevacizumab treatment of central retinal vein occlusion. Am J Ophthalmol 2007;144:864-71.
    • (2007) Am J Ophthalmol , vol.144 , pp. 864-871
    • Ferrara, D.C.1    Koizumi, H.2    Spaide, R.F.3
  • 23
    • 42449094689 scopus 로고    scopus 로고
    • Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: Results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up
    • Wu L, Arevalo JF, Roca JA, et al. Comparison of two doses of intravitreal bevacizumab (Avastin) for treatment of macular edema secondary to branch retinal vein occlusion: results from the Pan-American Collaborative Retina Study Group at 6 months of follow-up. Retina 2008;28:212-19.
    • (2008) Retina , vol.28 , pp. 212-219
    • Wu, L.1    Arevalo, J.F.2    Roca, J.A.3
  • 24
    • 64849111444 scopus 로고    scopus 로고
    • Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial
    • Prager F, Michels S, Kriechbaum K, et al. Intravitreal bevacizumab (Avastin) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial. Br J Ophthalmol 2009;93:452-6.
    • (2009) Br J Ophthalmol , vol.93 , pp. 452-456
    • Prager, F.1    Michels, S.2    Kriechbaum, K.3
  • 25
    • 65249132359 scopus 로고    scopus 로고
    • Pegaptanib sodium for macular edema secondary to central retinal vein occlusion
    • Wroblewski JJ, Wells JA III, Adamis AP, et al. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 2009;127:374-80.
    • (2009) Arch Ophthalmol , vol.127 , pp. 374-380
    • Wroblewski, J.J.1    Wells III, J.A.2    Adamis, A.P.3
  • 26
    • 33749445317 scopus 로고    scopus 로고
    • Ranibizumab for neovascular age-related macular degeneration
    • MARINA Study Group
    • Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. MARINA Study Group. N Engl J Med 2006;355:1419-31.
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 29
    • 0028802677 scopus 로고
    • Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion: The Central Vein Occlusion Study Group M Report
    • Central Retinal Vein Occlusion Study Group
    • Central Retinal Vein Occlusion Study Group. Evaluation of grid pattern photocoagulation for macular edema in central retinal vein occlusion: the Central Vein Occlusion Study Group M Report. Ophthalmology 1995;102:1425-33.
    • (1995) Ophthalmology , vol.102 , pp. 1425-1433
  • 30
    • 0021221946 scopus 로고
    • Argon laser photocoagulation for macular edema in branch vein occlusion
    • Branch Vein Occlusion Study Group
    • Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol 1984;98:271-82.
    • (1984) Am J Ophthalmol , vol.98 , pp. 271-282
  • 31
    • 0034787541 scopus 로고    scopus 로고
    • Radial optic neurotomy for central retinal vein occlusion: A retrospective pilot study of 11 consecutive cases
    • Opremcak EM, Bruce RA, Lomeo MD, et al. Radial optic neurotomy for central retinal vein occlusion: a retrospective pilot study of 11 consecutive cases. Retina 2001;21:408-15.
    • (2001) Retina , vol.21 , pp. 408-415
    • Opremcak, E.M.1    Bruce, R.A.2    Lomeo, M.D.3
  • 32
    • 0031884450 scopus 로고    scopus 로고
    • Laser-induced chorioretinal anastomosis for nonischemic central or branch retinal vein occlusion
    • Fermat S, Goldberg MF, Finkelstein D. Laser-induced chorioretinal anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 1998;116:43-52.
    • (1998) Arch Ophthalmol , vol.116 , pp. 43-52
    • Fermat, S.1    Goldberg, M.F.2    Finkelstein, D.3
  • 33
    • 0036627274 scopus 로고    scopus 로고
    • Radial optic neurotomy for central retinal vein occlusion (correspondence)
    • Hayreh SS. Radial optic neurotomy for central retinal vein occlusion (correspondence). Retina 2002;22:374-7.
    • (2002) Retina , vol.22 , pp. 374-377
    • Hayreh, S.S.1
  • 34
    • 0036734578 scopus 로고    scopus 로고
    • Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion
    • Ip MS, Kumar KS. Intravitreous triamcinolone acetonide as treatment for macular edema from central retinal vein occlusion. Arch Ophthalmol 2002;120:1217-21.
    • (2002) Arch Ophthalmol , vol.120 , pp. 1217-1221
    • Ip, M.S.1    Kumar, K.S.2
  • 35
    • 0041826878 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion
    • DOI 10.1016/S0002-9394(03)00228-9
    • Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 2003;136:419-25. (Pubitemid 37101237)
    • (2003) American Journal of Ophthalmology , vol.136 , Issue.3 , pp. 419-425
    • Park, C.H.1    Jaffe, G.J.2    Fekrat, S.3
  • 36
    • 3543128941 scopus 로고    scopus 로고
    • Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion
    • Bashshur ZF, Ma'luf RN, Allam S, et al. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Arch Ophthalmol 2004;122:1137-40.
    • (2004) Arch Ophthalmol , vol.122 , pp. 1137-1140
    • Bashshur, Z.F.1    Ma'Luf, R.N.2    Allam, S.3
  • 37
    • 33747075399 scopus 로고    scopus 로고
    • Intravitreal triamcinolone acetonide: A chance in a paradigm
    • Jonas JB. Intravitreal triamcinolone acetonide: a chance in a paradigm. Ophthalmic Res 2006;38:218-45.
    • (2006) Ophthalmic Res , vol.38 , pp. 218-245
    • Jonas, J.B.1
  • 38
    • 81255208019 scopus 로고    scopus 로고
    • A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion Study (SCORE) study report 5
    • Ip MS, VanVeldhiusen PC, Oden NL, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion Study (SCORE) study report 5. Arch Ophthalmol 2009;127:1101-14.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1101-1114
    • Ip, M.S.1    VanVeldhiusen, P.C.2    Oden, N.L.3
  • 39
    • 77956369658 scopus 로고    scopus 로고
    • A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch vein occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion Study (SCORE) study report 6
    • Scott IU, VanVeldhiusen PC, Oden NL, et al. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion Study (SCORE) study report 6. Arch Ophthalmol 2009;127:1115-28.
    • (2009) Arch Ophthalmol , vol.127 , pp. 1115-1128
    • Scott, I.U.1    VanVeldhiusen, P.C.2    Oden, N.L.3
  • 40
    • 57149091202 scopus 로고    scopus 로고
    • Pegaptanib sodium for neovascular age-related macular degeneration: Third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial
    • Singerman LJ, Masonson H, Patel M, et al. Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial. Br J Ophthalmol 2008;92:1606-11.
    • (2008) Br J Ophthalmol , vol.92 , pp. 1606-1611
    • Singerman, L.J.1    Masonson, H.2    Patel, M.3
  • 41
    • 41149085598 scopus 로고    scopus 로고
    • Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator
    • Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator. Mol Ther 2008;6:791-9.
    • (2008) Mol Ther , vol.6 , pp. 791-799
    • Campochiaro, P.A.1    Hafiz, G.2    Shah, S.M.3
  • 42
    • 52949116090 scopus 로고    scopus 로고
    • Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions
    • Pieramici DJ, Rabena M, Castellarin AA, et al. Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions. Ophthalmology 2008;115:e47-54.
    • (2008) Ophthalmology , vol.115
    • Pieramici, D.J.1    Rabena, M.2    Castellarin, A.A.3
  • 43
    • 58349122638 scopus 로고    scopus 로고
    • Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion
    • Spaide RF, Chang LK, Klancnik JM, et al. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 2009;147:298-306.
    • (2009) Am J Ophthalmol , vol.147 , pp. 298-306
    • Spaide, R.F.1    Chang, L.K.2    Klancnik, J.M.3
  • 44
    • 34247231572 scopus 로고    scopus 로고
    • Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease
    • DOI 10.1097/IAE.0b013e31804a7af2, PII 0000698220070400000004
    • Matsumoto Y, Freud KB, Peiretti E, et al. Rebound macular edema following bevacizumab (Avastin) therapy for retinal venous occlusive disease. Retina 2007;27:426-31. (Pubitemid 46624281)
    • (2007) Retina , vol.27 , Issue.4 , pp. 426-431
    • Matsumoto, Y.1    Freund, K.B.2    Peiretti, E.3    Cooney, M.J.4    Ferrara, D.C.A.C.5    Yannuzzi, L.A.6
  • 45
    • 38349172455 scopus 로고    scopus 로고
    • Randomized, double-masked, sham-controlled trial of ranibizumab for age-related macular degeneration: PIER Study year 1
    • Regillo CD, Brown DM, Abraham P, et al. Randomized, double-masked, sham-controlled trial of ranibizumab for age-related macular degeneration: PIER Study year 1. Am J Ophthalmol 2008;145:239-48.
    • (2008) Am J Ophthalmol , vol.145 , pp. 239-248
    • Regillo, C.D.1    Brown, D.M.2    Abraham, P.3
  • 46
    • 62649161064 scopus 로고    scopus 로고
    • Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab
    • Funk M, Kriechbaum K, Prager F, et al. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest Ophthalmol Vis Sci 2009;50:1025-32.
    • (2009) Invest Ophthalmol Vis Sci , vol.50 , pp. 1025-1032
    • Funk, M.1    Kriechbaum, K.2    Prager, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.